Grever MR - Search Results

1

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein.

Aron JL, Parthun MR, Marcucci G, Kitada S, Mone AP, Davis ME, Shen T, Murphy T, Wickham J, Kanakry C, Lucas DM, Reed JC, Grever MR, Byrd JC. Aron JL, et al. Among authors: grever mr. Blood. 2003 Jul 15;102(2):652-8. doi: 10.1182/blood-2002-12-3794. Epub 2003 Mar 20. Blood. 2003. PMID: 12649137 Free article.

2

Pharmacologic marrow purging in murine T cell leukemia.

Copelan EA, Johnson SC, Grever MR, Sheridan JF, Tutschka PJ. Copelan EA, et al. Among authors: grever mr. Blood. 1988 Jun;71(6):1656-61. Blood. 1988. PMID: 2836002 Free article.

3

Long-term follow-up of patients with hairy cell leukemia after treatment with 2'-deoxycoformycin.

Kraut EH, Grever MR, Bouroncle BA. Kraut EH, et al. Among authors: grever mr. Blood. 1994 Dec 15;84(12):4061-3. Blood. 1994. PMID: 7994024 Free article. Clinical Trial.

4

Introduction: chronic lymphocytic leukemia.

Byrd JC, Flinn IW, Grever MR. Byrd JC, et al. Among authors: grever mr. Semin Oncol. 1998 Feb;25(1):4-5. Semin Oncol. 1998. PMID: 9482520 No abstract available.

5

Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goals.

Byrd JC, Rai KR, Sausville EA, Grever MR. Byrd JC, et al. Among authors: grever mr. Semin Oncol. 1998 Feb;25(1):65-74. Semin Oncol. 1998. PMID: 9482528 Review.

6

Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.

Byrd JC, Shinn C, Waselenko JK, Fuchs EJ, Lehman TA, Nguyen PL, Flinn IW, Diehl LF, Sausville E, Grever MR. Byrd JC, et al. Among authors: grever mr. Blood. 1998 Nov 15;92(10):3804-16. Blood. 1998. PMID: 9808574 Free article.

7

Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells.

Byrd JC, Shinn C, Ravi R, Willis CR, Waselenko JK, Flinn IW, Dawson NA, Grever MR. Byrd JC, et al. Among authors: grever mr. Blood. 1999 Aug 15;94(4):1401-8. Blood. 1999. PMID: 10438728 Free article.

8

Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders.

Byrd JC, Grever MR, Waselenko JK, Willis CR, Park K, Goodrich A, Lucas MA, Shinn C, Flinn IW. Byrd JC, et al. Among authors: grever mr. Semin Oncol. 2000 Apr;27(2 Suppl 5):37-40. Semin Oncol. 2000. PMID: 10877050

9

Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.

Waselenko JK, Grever MR, Beer M, Lucas MA, Byrd JC. Waselenko JK, et al. Among authors: grever mr. Semin Oncol. 2000 Apr;27(2 Suppl 5):44-51. Semin Oncol. 2000. PMID: 10877052 Review.

10

Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies.

Flinn IW, Byrd JC, Morrison C, Jamison J, Diehl LF, Murphy T, Piantadosi S, Seifter E, Ambinder RF, Vogelsang G, Grever MR. Flinn IW, et al. Among authors: grever mr. Blood. 2000 Jul 1;96(1):71-5. Blood. 2000. PMID: 10891432 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters